Product Code: ETC6500711 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil CINV Existing and Pipeline Drugs Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil CINV Existing and Pipeline Drugs Market - Industry Life Cycle |
3.4 Brazil CINV Existing and Pipeline Drugs Market - Porter's Five Forces |
3.5 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume Share, By Major Drug, 2021 & 2031F |
4 Brazil CINV Existing and Pipeline Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) in Brazil |
4.2.2 Growing adoption of advanced therapies and drugs for CINV treatment |
4.2.3 Rising healthcare expenditure and investments in oncology care in Brazil |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new CINV drugs in Brazil |
4.3.2 High cost associated with advanced CINV treatments |
4.3.3 Limited access to specialized healthcare facilities in certain regions of Brazil |
5 Brazil CINV Existing and Pipeline Drugs Market Trends |
6 Brazil CINV Existing and Pipeline Drugs Market, By Types |
6.1 Brazil CINV Existing and Pipeline Drugs Market, By Major Drug |
6.1.1 Overview and Analysis |
6.1.2 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Major Drug, 2021- 2031F |
6.1.3 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Aloxi (Palonosetron), 2021- 2031F |
6.1.4 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Zofran Generic (Ondansetron), 2021- 2031F |
6.1.5 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Kytril Generic (Granisetron), 2021- 2031F |
6.1.6 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Emend (Aprepitant), 2021- 2031F |
6.1.7 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By Akynzeo (Netupitant-Palonosetron), 2021- 2031F |
6.1.8 Brazil CINV Existing and Pipeline Drugs Market Revenues & Volume, By SUSTOL (Extended Release Granisetron Injection), 2021- 2031F |
7 Brazil CINV Existing and Pipeline Drugs Market Import-Export Trade Statistics |
7.1 Brazil CINV Existing and Pipeline Drugs Market Export to Major Countries |
7.2 Brazil CINV Existing and Pipeline Drugs Market Imports from Major Countries |
8 Brazil CINV Existing and Pipeline Drugs Market Key Performance Indicators |
8.1 Patient satisfaction levels with CINV treatment options |
8.2 Number of clinical trials for new CINV drugs conducted in Brazil |
8.3 Adoption rate of innovative CINV therapies in major healthcare facilities in Brazil |
9 Brazil CINV Existing and Pipeline Drugs Market - Opportunity Assessment |
9.1 Brazil CINV Existing and Pipeline Drugs Market Opportunity Assessment, By Major Drug, 2021 & 2031F |
10 Brazil CINV Existing and Pipeline Drugs Market - Competitive Landscape |
10.1 Brazil CINV Existing and Pipeline Drugs Market Revenue Share, By Companies, 2024 |
10.2 Brazil CINV Existing and Pipeline Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |